BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/17/2023 8:44:11 AM | Browse: 22 | Download: 3
Publication Name |
World Journal of Gastrointestinal Pharmacology and Therapeutics |
Manuscript ID |
88566 |
Country/Territory |
United States |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Case Control Study |
Article Title |
Effectiveness of an amino acid beverage formulation in diarrhea-predominant irritable bowel syndrome: A pragmatic real-world study
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Samantha E Niles, Phil Blazy, Samuel N Cheuvront, Robert W Kenefick, Sadasivan Vidyasagar, Adam B Smith, Neil Fawkes and William Denman |
Funding Agency and Grant Number |
|
Corresponding Author |
Samantha E Niles, BSc, MS, Researcher, Department of Research and Development, Entrinsic Bioscience, 500 River Ridge Dr. 100, Norwood, MA 02062, United States. sniles@entrinsic.com |
Key Words |
Diarrhea-predominant irritable bowel syndrome; Amino acid beverage formulation; Pragmatic real-world study; Medical food; Bristol Stool Form Scale; Irritable Bowel Syndrome – Severity Scoring System |
Core Tip |
Amino-acid based medical foods have been shown to alleviate symptoms of drug induced gastrointestinal side effects, especially diarrhea severity. Diarrhea predominant irritable bowel syndrome (IBS-D) is a chronic gastrointestinal disorder that affects up to 9% of people worldwide. In this pragmatic, real-world study, an amino acid beverage was demonstrated to be tolerable and efficacious when used as an adjunct to standard of care for adults with IBS-D. Participants demonstrated improvements in both overall irritable bowel syndrome symptom severity and IBS-D symptoms within just two weeks. These results suggest that this amino acid-based beverage can be safely integrated into IBS-D standard of care for symptom improvement. |
Citation |
Niles SE, Blazy P, Cheuvront SN, Kenefick RW, Vidyasagar S, Smith AB, Fawkes N, Denman W. Effectiveness of an amino acid beverage formulation in diarrhea-predominant irritable bowel syndrome: A pragmatic real-world study. World J Gastrointest Pharmacol Ther 2023; In press |
 |
Received |
|
2023-09-29 14:03 |
 |
Peer-Review Started |
|
2023-09-29 14:03 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-10-10 19:17 |
 |
Revised |
|
2023-10-16 15:14 |
 |
Second Decision |
|
2023-11-10 04:17 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Company Editor-in-Chief |
|
2023-11-17 08:44 |
 |
Articles in Press |
|
2023-11-17 08:44 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
2150-5349 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Assistant Editor |
Assistant Editor |
Science Editor |
Cong Lin |
Reviewer Code |
04451514, 06730456, 02536349, 00068348, 06730456, and 02536349 |
Editorial Director |
|
Journal Chief Editor |
|
Company Chief Editor |
Jin-Lei Wang |
Language Editor |
|
Production Editor |
|
Responsible Production Editor |
|
Responsible Science Editor |
|
Proofing Editorial Director |
Jin-Lei Wang |
Proofing Editor-in-Chief |
Lian-Sheng Ma |
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345